Items where authors include "Reinmuth, N."

Article

Peters, S., Letovanec, I., Mauer, M. et al. (15 more authors) (2023) Assessment of RANK/RANK-L prevalence and clinical significance in NSCLC European Thoracic Oncology Platform Lungscape cohort and SPLENDOUR randomized clinical trial. Lung Cancer, 175. pp. 141-151. ISSN 0169-5002

Peters, S., Danson, S. orcid.org/0000-0002-3593-2890, Hasan, B. et al. (35 more authors) (2020) A randomized open-label phase III trial evaluating the addition of denosumab to standard first-line treatment in advanced NSCLC : the European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR trial. Journal of Thoracic Oncology, 15 (10). pp. 1647-1656. ISSN 1556-0864

Goldman, J.W., Garassino, M.C., Chen, Y. et al. (17 more authors) (2020) Patient-reported outcomes with first-line durvalumab plus platinum-etoposide versus platinum-etoposide in extensive-stage small-cell lung cancer (CASPIAN): a randomized, controlled, open-label, phase III study. Lung Cancer, 149. pp. 46-52. ISSN 0169-5002